تأثیر فعالیت ورزشی هوازی و محدودیت کالریک بر سطوح آدروپین و شاخص مقاومت به انسولین در زنان چاق کم‌تحرک

1. Aydin S. Three new players in energy regulation: Preptin, adropin and irisin. Peptides. 2014; 56: 94–110.
2. Van Gaal L F, Mertens I L, De Block C E. Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444‌(7121): 875-80.
3. Aydin S, Kuloglu T, Nesimi M, Yilmaz M, Kalayci M, Sahin I, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem. 2013; 380‌(1): 73-81.
4. Gao S, McMillan R P, Jacas J, Zhu Q, Li X, Kumar G K, et al. Regulation of substrate oxidation preferences in muscle by the Peptide Hormone Adropin. Diabetes. 2014; 63(10): 324-52.
5. Kumar K G, Trevaskis J L, Lam D D, Sutton G M, Koza R A, Chouljenko V N, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008; 8: 468–81.
6. Kumar K G, Zhang J, Gao S, Rossi J, McGuinness O P, Halem H H, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012; 20: 1394–402.
7. Butler A A, Tam C S, Stanhope K L, Wolfe B M, Ali M R, O’Keeffe M, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012; 97: 3783–91.
8. Sayın O, Tokgöz Y, Arslan N. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab. 2014; 27(5-6): 479-84.
9. Lefevre M, Redmana L M, Heilbronn L K. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis. 2009; 203: 206–13.
10. Douglas CC, Lawrence JC, Bush NC, Oster RA, Gower BA, Darnell BE, et al. Ability of the Harris Benedict formula to predict energy requirements differs with weight history and ethnicity. Nutr Res. 2007; 27(4):194-199.
11. Mallinson R J, Williams N I, Olmsted M P, Scheid J L, Riddle E S. A case report of recovery of menstrual function following a nutritional intervention in two exercising women with amenorrhea of varying duration. J Int Soc Sports Nutr. 2013; 2: 10-34.
12. Altincik A, Sayin O. Evaluation of the relationship between serum adropin levels and blood pressure in obese children. J Pediatr Endocrinol Metab. 2015, 28(9-10): 1095-1100.
13. Kwak M S, Kim D, Chung G E, Kim W, Kim Y J, Yoon J H. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int. 2015; 35(3): 944–52.
14. Gao S, McMillan R P, Zhu Q, Lopaschuk G D, Bulter A, Hulver M W. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab. 2015; 4(4): 310-24.
15. Wong C M, Wang Y, Lee J T, Wu D, Xu A, Ling K S. Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/ Notch signaling pathway in Mice. J Biol Chem. 2014; 289: 25976-86.
16. Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014; 52(5): 751–8.